Benzinga - by Chris Katje, Benzinga Staff Writer. Congressman Bernie Sanders (I-Vt.) has been known to tussle with public companies over their high prices or anticompetitive...
Benzinga - by Chris Katje, Benzinga Staff Writer. Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five...
Mizuho Securities initiated coverage on Vaxcyte Inc (NASDAQ: PCVX), a vaccine company targeting bacterial infectious diseases (primarily for disease prevention). Lead asset VAX-24...
Benzinga - by Piero Cingari, Benzinga Staff Writer. Investors are always on the lookout for untapped opportunities, especially in stocks that have been heavily discounted and now...
Two of the university leaders refused to say that calling for the genocide of Jews was against their schools’ policies, saying it depended on the context.
Arvinas Inc (NASDAQ: ARVN) and Pfizer Inc (NYSE: PFE) released clinical data for vepdegestrant (ARV-471) in combination with palbociclib (IBRANCE). Interim results from the Phase...
Pfizer Inc. (NYSE:PFE) today presented results from the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab for the treatment of people with severe...
Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO® (elranatamab). ELREFXIO is a targeted...